ProMetic Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: axial	4/17/2019 4:28:55 PM
	of 250

Unless there's a change in refinancing this investment is a writeoff. Management's intent is to severely cut the percentage of retail investor ownership in Prometic. Please see A Retail Investor's Look At Prometic's Refinancing Plan by C.C. Abbott. The change in ownership varies for Prometic shareholders — For Non-SALP (i.e., retail) shareholders, the % ownership drops by 76.7% (=96.7-20) — For SALP, the % ownership increases by 63.7% (=67-3.3) — For Consonance, the % ownership increases by 13% (=13-0) ___________________________________________________ Limitations on the Rights Offering -- a cap -- distort its value to retail investors. Summary in this table: Ugly.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next